Cite
HARVARD Citation
Clay, T. et al. (2019). Warfarin is not the anticoagulant of choice for malignancy‐associated venous thromboembolism. Internal medicine journal. 49 (7), p. 934. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Clay, T. et al. (2019). Warfarin is not the anticoagulant of choice for malignancy‐associated venous thromboembolism. Internal medicine journal. 49 (7), p. 934. [Online].